NCT05499195View on ClinicalTrials.gov

Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic Resection

CompletedOBSERVATIONAL
Enrollment

159

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

May 15, 2022

Study Completion Date

June 30, 2022

Conditions
Esophageal Cancer
Trial Locations (1)

Unknown

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences

OTHER

NCT05499195 - Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic Resection | Biotech Hunter | Biotech Hunter